OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
3303$52.0056

Univacco Technology Inc

Commodity ChemicalsVerified

Univacco Technology Inc has a market capitalization of TWD 4.86 billion and a price-to-earnings ratio of 11.36, indicating a relatively moderate valuation compared to earnings. The company's price-to-book ratio is 2.01, suggesting that the market values the company at twice its book value. The enterprise value to EBITDA ratio is 12.46, and the enterprise value to revenue ratio is 1.94, both of which are standard metrics for valuing companies in the chemicals industry. In terms of profitability, the company's return on equity is 17.67%, and its return on assets is 10.64%, both of which are strong indicators of efficient use of equity and assets. The gross profit margin is 37.53%, and the operating margin is 15.53%, which are in line with the industry's typical performance metrics. The company's revenue is primarily concentrated in the domestic market and overseas markets, including the Americas, Europe, and mainland China. The geographic exposure is broad, but the company does not disclose specific revenue percentages by region, making it difficult to assess concentration risk. The company's growth trajectory is positive, with a current fiscal year outlook indicating a revenue increase. The company's capital expenditure is negative, suggesting a reduction in investment in new projects or facilities. The free cash flow is positive at TWD 236.22 million, indicating the company has sufficient cash to fund operations and potentially return value to shareholders. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag is the negative net cash position after subtracting total debt, which could affect the company's ability to meet short-term obligations. The dilution potential is low, and no significant adjustments have been applied to the valuation metrics. Recent events include the company's 2023 annual report, which provides insights into its financial performance and strategic direction. The report highlights the company's focus on expanding its product line and maintaining a strong presence in the global market.

30-day price · 3303+2.50 (+5.5%)
Low$45.10High$54.60Close$47.90As of21 May, 00:00 UTC
Profile
CompanyUnivacco Technology Inc
Ticker3303.TWO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Univacco Technology Inc is a Taiwan-based company engaged in the manufacturing, processing, and sales of vacuum evaporated films, including hot foil, cold foil, laser foil, digital foil, and plastic foil, primarily used in printing, packaging, and labels.

Classification. Univacco Technology Inc is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92.

Univacco Technology Inc has a market capitalization of TWD 4.86 billion and a price-to-earnings ratio of 11.36, indicating a relatively moderate valuation compared to earnings. The company's price-to-book ratio is 2.01, suggesting that the market values the company at twice its book value. The enterprise value to EBITDA ratio is 12.46, and the enterprise value to revenue ratio is 1.94, both of which are standard metrics for valuing companies in the chemicals industry. In terms of profitability, the company's return on equity is 17.67%, and its return on assets is 10.64%, both of which are strong indicators of efficient use of equity and assets. The gross profit margin is 37.53%, and the operating margin is 15.53%, which are in line with the industry's typical performance metrics. The company's revenue is primarily concentrated in the domestic market and overseas markets, including the Americas, Europe, and mainland China. The geographic exposure is broad, but the company does not disclose specific revenue percentages by region, making it difficult to assess concentration risk. The company's growth trajectory is positive, with a current fiscal year outlook indicating a revenue increase. The company's capital expenditure is negative, suggesting a reduction in investment in new projects or facilities. The free cash flow is positive at TWD 236.22 million, indicating the company has sufficient cash to fund operations and potentially return value to shareholders. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag is the negative net cash position after subtracting total debt, which could affect the company's ability to meet short-term obligations. The dilution potential is low, and no significant adjustments have been applied to the valuation metrics. Recent events include the company's 2023 annual report, which provides insights into its financial performance and strategic direction. The report highlights the company's focus on expanding its product line and maintaining a strong presence in the global market.
Key takeaways
  • Univacco Technology Inc has a strong return on equity and return on assets, indicating efficient use of capital.
  • The company's valuation metrics, including price-to-earnings and enterprise value to EBITDA, are in line with industry standards.
  • The company's liquidity risk is medium, and its dilution risk is low, suggesting a stable capital structure.
  • The company's free cash flow is positive, indicating the ability to fund operations and potentially return value to shareholders.
  • The company's geographic exposure is broad, but specific revenue concentration by region is not disclosed.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "The company's gross profit margin and operating margin are in line with industry standards, indicating stable profitability.",
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$3.01B
Gross profit$1.13B
Operating income$467.0M
Net income$428.3M
R&D
SG&A
D&A
SBC
Operating cash flow-$25.5M
CapEx-$109.5M
Free cash flow$236.2M
Total assets$4.03B
Total liabilities$1.60B
Total equity$2.42B
Cash & equivalents$19.8M
Long-term debt$976.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$3.01B$467.0M$428.3M$236.2M
FY-1$2.99B$529.3M$366.4M$232.4M
FY-2$2.46B$228.5M$208.3M$36.8M
FY-3$2.81B$290.4M$274.3M$165.7M
FY-4$2.85B$379.6M$150.6M$15.7M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$4.03B$2.42B$19.8M
FY-1$3.69B$2.25B$55.0M
FY-2$3.09B$1.96B$6.0M
FY-3$3.13B$1.95B
FY-4$3.50B$1.79B$0.00
PeriodOCFCapExFCFSBC
FY0-$25.5M-$109.5M$236.2M
FY-1$468.6M-$132.7M$232.4M
FY-2$440.7M-$132.6M$36.8M
FY-3$377.0M-$121.2M$165.7M
FY-4$295.1M-$152.4M$15.7M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$705.6M$76.0M$97.7M$130.1M
FQ-1$800.4M$99.9M$149.0M$143.3M
FQ-2$756.0M$156.6M$69.1M$86.9M
FQ-3$745.3M$134.5M$112.6M$134.8M
FQ-4$716.1M$103.0M$86.4M$85.8M
FQ-5$872.9M$167.5M$128.0M$140.9M
FQ-6$758.5M$165.4M$65.3M$72.6M
FQ-7$645.3M$93.4M$86.8M$98.8M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$4.03B$2.42B$19.8M
FQ-1$4.01B$2.31B$175.4M
FQ-2$3.82B$2.10B$156.2M
FQ-3$3.79B$2.12B$95.2M
FQ-4$3.69B$2.25B$55.0M
FQ-5$3.43B$2.11B$45.0M
FQ-6$3.30B$1.97B$34.1M
FQ-7$3.16B$1.90B$92.0M
PeriodOCFCapExFCFSBC
FQ0-$25.5M-$109.5M$130.1M
FQ-1$77.7M-$96.6M$143.3M
FQ-2$149.0M-$47.4M$86.9M
FQ-3$70.0k-$22.1M$134.8M
FQ-4$468.6M-$132.7M$85.8M
FQ-5$308.1M-$88.0M$140.9M
FQ-6$203.1M-$57.8M$72.6M
FQ-7$105.3M-$25.6M$98.8M
Valuation
Market price$52.00
Market cap$4.86B
Enterprise value$5.82B
P/E11.4
Reported non-GAAP P/E
EV/Revenue1.9
EV/Op income12.5
EV/OCF
P/B2.0
P/Tangible book2.0
Tangible book$2.42B
Net cash-$956.4M
Current ratio2.8
Debt/Equity0.4
ROA10.6%
ROE17.7%
Cash conversion-6.0%
CapEx/Revenue-3.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric3303Activity
Op margin15.5%0.4% medp25 -8.0% · p75 16.0%above median
Net margin14.2%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin37.5%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity40.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 00:39 UTC#c2cbbd92
Market quoteclose TWD 52.00 · shares 0.09B diluted
no public URL
2026-05-11 00:39 UTC#19e55074
Source: analysis-pipeline (hybrid)Generated: 2026-05-11 00:41 UTCJob: 0fd3173f